Cannell & Co. Accelerate Diagnostics, Inc Transaction History

Cannell & Co.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	SELL	$0.51 - $17.1 $5,100 - $171,000	-10,000 Reduced 0.89%	1,111,919 $789,000
Q3 2022 Nov 02, 2022	BUY	$1.01 - $17.0 $35,350 - $595,000	35,000 Added 3.22%	1,121,919 $1.71 Million
Q4 2021 Feb 09, 2022	SELL	$4.27 - $6.97 $12,809 - $20,910	-3,000 Reduced 0.28%	1,086,919 $5.67 Million
Q3 2021 Nov 10, 2021	SELL	$5.31 - $8.25 $26,549 - $41,250	-5,000 Reduced 0.46%	1,089,919 $6.35 Million
Q2 2021 Aug 09, 2021	SELL	$6.81 - $9.23 $17,025 - $23,075	-2,500 Reduced 0.23%	1,094,919 $8.83 Million
Q1 2021 May 07, 2021	SELL	$7.99 - $15.0 $126,401 - $237,300	-15,820 Reduced 1.42%	1,097,419 $9.13 Million
Q4 2020 Feb 11, 2021	SELL	$7.04 - $11.7 $36,608 - $60,839	-5,200 Reduced 0.46%	1,113,239 $8.44 Million
Q2 2020 Aug 07, 2020	BUY	$7.49 - $15.16 $172,270 - $348,680	23,000 Added 2.1%	1,118,439 $17 Million
Q4 2019 Feb 10, 2020	SELL	$14.6 - $18.13 $281,780 - $349,909	-19,300 Reduced 1.73%	1,095,439 $18.5 Million
Q3 2019 Nov 12, 2019	SELL	$16.62 - $23.92 $8,310 - $11,960	-500 Reduced 0.04%	1,114,739 $20.7 Million
Q2 2018 Aug 06, 2018	SELL	$19.02 - $24.95 $22,824 - $29,940	-1,200 Reduced 0.11%	1,115,239 $24.9 Million
Q1 2018 May 09, 2018	SELL	$22.55 - $29.9 $90,200 - $119,600	-4,000 Reduced 0.36%	1,116,439 $25.5 Million
Q4 2017 Feb 13, 2018	BUY	$18.0 - $30.0 $435,600 - $726,000	24,200 Added 2.21%	1,120,439 $29.4 Million
Q3 2017 Nov 08, 2017	BUY	$21.1 - $25.15 $23.1 Million - $27.6 Million	1,096,239	1,096,239 $24.6 Million

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $191M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Cannell & Co., based on Form 13F filings with the SEC.

Stay updated on Cannell & Co. with notifications on news.